Chimerix Inc
Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases in the United States. Its product pipeline comprising dordaviprone (ONC201), which is in phase 3 clinical-stage development for H3 K27M-mutant diffuse glioma, as well as in phase 2 Investigator Initiated Clinical Trials for multiple oncology studies; and ONC206, a sec… Read more
Chimerix Inc (CMRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: -0.158x
Based on the latest financial reports, Chimerix Inc (CMRX) has a cash flow conversion efficiency ratio of -0.158x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-19.27 Million) by net assets ($121.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Chimerix Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Chimerix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Chimerix Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chimerix Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Foshan Saturday Shoes Co Ltd
SHE:002291
|
-0.028x |
|
Robinsons Retail Holdings Inc
PINK:RRETY
|
0.037x |
|
CrossFirst Bankshares Inc
NASDAQ:CFB
|
0.041x |
|
SANGETSU CO LTD
OTCGREY:SGSUF
|
N/A |
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D
IS:KRDMD
|
0.031x |
|
Hunan Changgao High Voltage Switchgear Group Co Ltd
SHE:002452
|
0.062x |
|
GREENTOWN SVC.G.HD-00001
F:GR1
|
N/A |
|
NextNav Inc. Warrant
NASDAQ:NNAVW
|
0.405x |
Annual Cash Flow Conversion Efficiency for Chimerix Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Chimerix Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $121.68 Million | $-74.98 Million | -0.616x | -72.16% |
| 2023-12-31 | $193.03 Million | $-69.09 Million | -0.358x | -96.16% |
| 2022-12-31 | $256.86 Million | $-46.87 Million | -0.182x | +87.54% |
| 2021-12-31 | $68.25 Million | $-99.93 Million | -1.464x | -198.11% |
| 2020-12-31 | $73.38 Million | $-36.04 Million | -0.491x | +28.17% |
| 2019-12-31 | $109.95 Million | $-75.18 Million | -0.684x | -126.04% |
| 2018-12-31 | $177.60 Million | $-53.73 Million | -0.302x | -33.86% |
| 2017-12-31 | $221.81 Million | $-50.12 Million | -0.226x | +2.18% |
| 2016-12-31 | $276.22 Million | $-63.81 Million | -0.231x | +22.41% |
| 2015-12-31 | $335.46 Million | $-99.89 Million | -0.298x | -73.71% |
| 2014-12-31 | $274.64 Million | $-47.08 Million | -0.171x | +33.91% |
| 2013-12-31 | $98.54 Million | $-25.56 Million | -0.259x | -96.39% |
| 2012-12-31 | $14.20 Million | $-1.88 Million | -0.132x | +95.13% |
| 2011-12-31 | $9.69 Million | $-26.28 Million | -2.713x | -- |